- Shares of bluebird bio (BLUE +27.9%) pop on a 5x surge in volume in response to its Q1 report after yesterday's close.
- Revenue: $6.3M (+473%); operating loss: ($10.7M) (-64.6%); net loss/share: ($0.44) vs ($19.94); cash & equiv: $192.5M (-6.7%); cash burn: ($11.9M).
- 153 mutual funds have positions, up from 73 a year earlier.
From other sites
at Benzinga.com (Feb 26, 2015)
at Benzinga.com (Feb 25, 2015)
at Benzinga.com (Jan 15, 2015)
at Nasdaq.com (Jan 14, 2015)
at Benzinga.com (Jan 13, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs